Q1 2026 Holdings
Filed 2026-05-05 | 13 holdings | $476.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| BridgeBio Pharma Inc. (Bbio)(BBIO) | COM | 10806X102 | $378.0M | 5,089,611 | 79.4% |
| Syndax Pharmaceuticals, Inc. (Sndx)(SNDX) | COM | 87164F105 | $30.8M | 1,316,806 | 6.5% |
| Monte Rosa Therapeutics Inc (Glue)(GLUE) | COM | 61225M102 | $25.6M | 1,555,664 | 5.4% |
| Bicara Therapeutics Inc. (Bcax)(BCAX) | COM | 055477103 | $11.3M | 568,919 | 2.4% |
| BridgeBio Oncology Therapeutics (Bbot)(BBOT) | COM NEW | 107924102 | $9.1M | 1,018,018 | 1.9% |
| Compass Pathways Plc (Cmps)(CMPS) | SPONSORED ADS | 20451W101 | $7.9M | 1,432,336 | 1.7% |
| Scholar Rock Holding Corporation (Srrk)(SRRK) | COM | 80706P103 | $3.8M | 77,031 | 0.8% |
| Biomea Fusion Inc (Bmea)(BMEA) | COM | 09077A106 | $3.1M | 2,048,757 | 0.7% |
| Eupraxia Pharmaceuticals Inc. (Eprx)(EPRX) | COM | 29842P105 | $2.4M | 325,000 | 0.5% |
| Urogen Pharma Ltd. (Urgn)(URGN) | COM | M96088105 | $1.9M | 108,000 | 0.4% |
| Aclaris Therapeutics Inc (Acrs)(ACRS) | COM | 00461U105 | $1.6M | 434,455 | 0.3% |
| Marker Therapeutics, Inc. (Mrkr)(MRKR) | COM NEW | 57055L206 | $423.0K | 325,370 | 0.1% |
| OnKure Therapeutics, Inc. (Okur)(OKUR) | COM CL A | 68277Q105 | $366.8K | 88,607 | 0.1% |